Foundation for innovation
in Cardiometabolism and Nutrition

Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC

Clinics and Research in Hepatology and Gastroenterology

Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC

Publié le 

Restez en contact

Recevez toute l’actualité de la fondation ICAN

This field is for validation purposes and should be left unchanged.

Nos fondateurs

CERTIFIÉ ISO 9001

Nos soutiens institutionnels

Notre réseau